Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases
Brendon L. Neuen(Royal North Shore Hospital), Gina Campestri(FIND), Niels Jongs(University Medical Center Groningen), Marijn M. Speeckaert(Ghent University Hospital), Kieran McCafferty(Queen Mary University of London), Paola Aguerre(FIND), Dafne Brodschi(FIND), Alfredo Chew‐Wong(Autonomous University of Aguascalientes), Glenn M. Chertow(Stanford Health Care), Rafaël Maldonado(FIND), Pablo E. Pérgola(Renal Associates P. A.), Jonathan Barratt(University of Leicester), Nicole Rethemeier(Bayer (Germany)), Tim Friede(Universitätsmedizin Göttingen), Rania Dayoub(University Hospital Regensburg), See Cheng Yeo(Tan Tock Seng Hospital), Arunkumar Subbiah(National Institute of Medical Statistics), Shuifu Tang(Queen Mary Hospital), Katharina Mueller(Bayer (Germany)), Na Li(Bayer (China)), Julio Bittar(FIND), Julia Cáceres(Centro de Investigación y Desarrollo), M. Arriola(FIND), C S P Lam(National University of Singapore), J David Smeijer(University Medical Center Groningen), V Perkovic(UNSW Sydney), D Cherney(University Health Network), K R Tuttle(Inland Northwest Health Services), Evangelos Papachristou(General University Hospital of Patras), David Packham(The Royal Melbourne Hospital), Rajiv Agarwal(Richard L. Roudebush VA Medical Center), Adeera Levin(FIND), Hiddo J. L. Heerspink(University Medical Center Groningen), Jay Elliott(Vertex Pharmaceuticals (United States)), Paula Arenas(FIND), Marina Yael Finkelsztein(Ecoserveis), Maria Bevilacqua(FIND), Johannes F.E. Mann(FIND), Pantelis Sarafidis(Aristotle University of Thessaloniki), Xiangmei Chen(FIND), Claudia Emilce Baccaro(FIND), Masaomi Nangaku(The University of Tokyo), Anna Burgner(Vanderbilt Health), Meike Brinker(Bayer (Germany)), Vladimir A. Dobronravov(First Pavlov State Medical University of St. Petersburg), Jürgen Floege(Universitätsklinikum Aachen), Christoph Wanner(University of Würzburg), Sydney CW Tang(Queen Mary Hospital), FIND-CKD Investigators, Mario Berger(Bayer (Germany))
Cited by 5
Related Papers
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients
|Journal of the American Society of Nephrology|2005|3.4k
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
|Journal of the American Society of Nephrology|2004|2.7k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k